|Biotechnology Information Institute|
|Our IP is For Sale! This includes the domain names BIOPHARMA.com, BIOPHARMA.org, the BIOPHARMA® U.S. Trademark, and >100 other 'BIOPHARMA(ceutical)' industry domains.|
The Biotechnology Information Institute (BII) develops unique,
high-end information resources and provides consulting serving critical needs of the biotechnology and pharmaceutical
communities, particularly concerning biopharmaceuticals and their manufacturing (bioprocessing).
As a sole proprietorship, Ronald A. Rader, President, is responsible for all of BII's products and services.
BII is currently concentrating on divesting its IP. BII databases, periodicals, books (none currently being sold) include:
|BIOPHARMA®: Biopharmaceutical Products in the U.S. and European Markets|
Newer additions to the BIOPHARMA® suite of information resources:
Biosimilars/Biobetters Pipeline Directory (Biosimilarspipeline.com)
U.S. BIOPHARMACOPEIA™ Registry of Biopharmaceutical Products
- 678-page book published in 1994; online database until early 2000
The Biotechnology Information Institute
offers consulting, specializing in information retrieval and analysis, competitive intelligence, technology assessment, market research and information resources development/publishing concerning biotechnology and pharmaceutical products, research, development, technologies, patents/technology transfer, marketing and public affairs.
See Mr. Rader's
bio and full